Agenda

Coming Soon

MASTERCLASSES
Tuesday, February 4, 2025
CONFERENCE DAY 1
Wednesday, February 5, 2025
CONFERENCE DAY 2
Thursday, February 6, 2025

Registration and Continental Breakfast

Driving Impact of Market Research with Senior Management

Refreshment Break

From Fiction to Function: Making Synthetic Data Work for Market Research

Learn when and how to trust AI-generated respondents without replacing Primary Research

Presented by Shapiro+Raj

Networking Lunch

New best practices in market research to support campaigns development

Presented by Fulcrum Research Group

Refreshment Break

Behavior Board™: The Role of PMR in Disrupting Customer Behavior

Great researchers can have a tremendous impact on helping organizations identify and disrupt misalignment between current and desired customer behaviors. Find out how going beyond what customers think and into the realm of all they do, can change brand strategy and patient outcomes. What may seem irrational, could be the brand’s opportunity through the Behavior Board™.

Presented by Veritas est

Masterclass Workshops Conclude

Registration & Breakfast in Exhibition Hall

Chairpersons’ Opening Remarks

Keynote: Market Research – A New Moat for Customer Engagement

Presented by Johnson & Johnson

Keynote: Harnessing Big Data and AI For Personalized Medicine: The Future of Pharma

This keynote will explore how big data and AI are transforming the pharmaceutical industry. We'll discuss their roles in accelerating drug discovery, enhancing personalized medicine, and optimizing supply chains. The speech will also cover market trends, and future challenges and opportunities. Join us to envision a patient-centric, innovative future for pharma.

Presented by Villanova University

NETWORKING & REFRESHMENTS IN EXHIBITION HALL

Keynote: Executive Level Boardroom Discussions

Presented by Aveo Oncology an LG Chem Company, Immunovant, J&J Innovative Medicine, Merck, Organon, Pfizer, Regeneron, and Sun Pharma

“ASK THE EXPERTS” INTERACTIVE ROUND TABLES

Explore and capture the power of participants’ Insights and experiences and exploration of these topics in this fun and informal environment in small groups. Choose 1 of 6 concurrent round tables.
ROUND TABLE 1
Best Practices in HCP Segmentation

Presented by Novartis

ROUND TABLE 2
Team Management

Presented by Ferring Pharmaceuticals

ROUND TABLE 3
Best Practices and Opportunities for Enhancing Insights Sharing Platforms & Portals

Presented by Merck KGaA

ROUND TABLE 4
Market Research & Forecasting: An Essential Partnership

Presented by Merck

ROUND TABLE 5
How Do We Still Generate Quality Insights When the Budget Is Tight?

Presented by Organon

ROUND TABLE 6
Segmentation, What’s the Point?

Presented by Pfizer

Networking Luncheon

Participants may choose 1 of 4 concurrent tracks

TRACK A

Can AI Chatbots Replace Moderators in Some Qual Studies?

Market researchers are working hard to find ways of incorporating AI-powered technologies into our work. In this talk we discuss the results of a collaboration between Fulcrum Research Group and Esperion Therapeutics to compare traditional IDIs with chat-bot moderated IDIs in a study to evaluate creative concepts.

Presented by Fulcrum Research Group and Esperion Therapeutics

TRACK B

An Innovative Methodology to Incorporate RWD into Demand Studies

Presented by SRI

TRACK C

Patient Journey: Where to Start and What to Pack

Patient Journeys are typically foundational and high profile – meaning there is a lot at stake when designing and executing. What are the must have elements when planning the research, what nice to haves could take it to the next level, and what are some common pitfalls to keep in mind (including what you miss out on by talking only to HCPs). This session will review the types of patient journey research that can be undertaken and key considerations to take into account, from the perspective of seasoned researchers, a pharma stakeholder, as well as a patient who is on their own journey with a health condition.

Presented by Health Union and Takeda

TRACK D

Beyond Silos: Unified Research Approaches to Understand Pharma’s Market Dynamics

In this talk, we’ll explore how the pharmaceutical and biotech markets are shaped by the interplay between customer needs and competitive forces. You’ll learn why isolating these perspectives—or combining their insights post hoc—can lead to incomplete or misleading conclusions. By targeting both dimensions simultaneously through expertly designed hybrid research methodologies, we’ll demonstrate how to uncover actionable insights that drive smarter, more holistic strategic decisions.

Presented by Lifescience Dynamics

PARTICIPANTS MAY CHOOSE 1 OF 4 CONCURRENT TRACKS

TRACK A

Strengthening Brand Performance and Loyalty by Investing in Patient Service

Presented by ThinkGen

TRACK B

Ethnic Disparities in the Treatment of Ovarian Cancer Versus Multiple Myeloma in the US: A Retrospective and Prospective Comparative Analysis

Presented by APLUSA

TRACK C

Empowering the Next Generation: Training and Professional Growth in the AI Era

• To explore how AI will redefine the roles and skill sets within healthcare market research

• To identify the evolving needs in professional development, with a focus on younger talent entering the industry
• To examine the points at which human expertise will continue to be essential alongside AI advancement
• To provide a framework for how agencies and client-side researchers can strategically adapt to AI without compromising the human element of research.

Presented by Day One Strategy

TRACK D

Redefining the Rules: A Disruptive Approach to Brand Positioning

In today’s competitive pharmaceutical landscape, effective brand positioning is critical for standing out and driving success.

This session, “Redefining the Rules: A Disruptive Approach to Brand Positioning,” explores how a comprehensive, multi-phased strategy rooted in behavioral sciences — spanning ideation, customer co-creation, development workshop, and rigorous testing— can redefine product launch. Attendees will gain insights into how disruptive thinking was applied to position a groundbreaking new drug, overcoming traditional barriers and resonating deeply with key stakeholders. Through this case study, learn actionable strategies to create impactful brand positions that not only meet market needs but also challenge conventions, ensuring meaningful differentiation and long-term competitive advantage.

Presented by integro and Merck

PARTICIPANTS MAY CHOOSE 1 OF 3 CONCURRENT TRACKS

TRACK A

Data-Driven Discipline: Unlocking Profitability in Small Molecule Generics

The small molecule generics market is a tough place to compete, and companies face pressures from customer consolidation to new market entrants and supply issues, which all put pressure on pricing and profitability. To succeed, generic businesses are becoming more agile, stepping up analytical rigor around pricing, market analysis and portfolio management. In this presentation we will review how generics businesses have revitalized their model to meet market challenges.

Presented by Wockhardt USA

TRACK B

Role of Insights in New Product Planning

Presented by EMD Serono

TRACK C

Gen AI Powered Digital Super KOL

Imagine a comprehensive data and insights repository on all things CML… a digital super KOL!

We compiled all market research content over the last two years and used genAI to synthesize the data and build a patient journey. Once tested and validated, this formed the backbone of our digital KOL. We can now use the digital KOL to get instant answers to a range of questions that we constantly grapple with – testing of multiple TPPs, impact of new Takeda and competitor data readouts, drivers and barriers, identifying untapped opportunity areas etc. – eventually we should also be able to run sensitivity analysis on sales and marketing tactics!

The Virtual super KOL is a “live” application that will continue to learn and evolve as we layer in external publications and additional work, ensuring insights are always up to date with the latest data.

Presented by Takeda

Networking and Refreshments in Exhibition Hall

PARTICIPANTS MAY CHOOSE 1 OF 4 CONCURRENT TRACKS

TRACK A

New Tools for Modeling Timing and Order-of-Entry Effects

Survey-based demand studies for pipeline products rarely provide good estimates of timing and order-of-entry effects as they arise mostly as a consequence of real-world prescribing experience.

Forecasters often rely on secondary data analogs to model the effects of timing and order-of- entry but these estimates often fail to capture the unique characteristics and market situations for pipeline products. This presentation shares new tools for modeling timing and order-of-entry that combine models based on secondary data with new metrics from survey-based demand research. Accuracy of the methodology is demonstrated with several case studies.

Presented by Viscadia

TRACK B

Qualitative Research: Can AI Truly Understand Human Stories?

AI platforms claim accuracy and time-savings for marketing researchers, so we decided to challenge two AI tools to a duel with human analysts.

We chose a common topic (Obesity and GLP-1 weight loss medications) in a particularly challenging methodology: the Patient Journey. This type of research yields some straightforward responses, but the majority of the output to be analyzed is narrative – respondent stories with a mix of factual details and emotional, social, and psychological impacts that we expected to challenge AI’s analysis capabilities.

Presented by MarketVision Research

TRACK C

The Giving Tree: a Smarter Approach to Conducting Research within Rare Disease

The team will present a case study that demonstrates a smarter approach to conducting research within rare disease. Facing challenges that include a small and hard to recruit physician population and concerns about oversampling, a global ATU has grown into a mock “community” that has been used to tackle multiple objectives across key stakeholders.

Presented by Branding Science and Merck

TRACK D

The Agility Advantage: Pharma & HCP Perspectives on a World of Unlimited Insights

What would a world of unlimited HCP insights look like? Hear directly from global pharma insights experts (and a physician!) as they share real-world applications and the tangible benefits of unlimited agile insights in optimizing go-to-market strategies. Oh, the places we’ll go!

Presented by Sermo and AstraZeneca

PARTICIPANTS MAY CHOOSE 1 OF 4 CONCURRENT TRACKS

TRACK A

Hear & See Emotion: Decoding Voices with Machine Learning & AI

At inVibe, we use machine learning technology to recognize and measure emotionality in our respondents’ voices when they’re speaking.

To humans who have spent a lifetime decoding emotion, this task seems very simple. However, getting a computer to decode emotions like a human can is a bit more complicated than it seems. In this session, we’ll explore exactly what it means to recognize emotion, what Speech Emotion Recognition (SER) is, how computers can reliably measure emotions, and how we can use SER to better understand the thoughts, beliefs, attitudes that explain and motivate behavior.

Presented by inVibe and Bristol Myers Squibb

TRACK B

Are Digital Twins Just Virtual or a Reality for Life Science Insights?

This session explores how digital twins can transform pharmaceutical market research by simulating patient behaviors and HCP decision-making. Through a case study, we’ll compare insights from digital twins with those from real respondents, demonstrating the potential use in certain types of patient and HCP research and implications for budget and timing. We will also address ethical considerations, including privacy, bias, and the importance of human oversight to ensure responsible and accurate outcomes in healthcare research.

Presented by KJT

TRACK C

Driving Greater Precision, Efficiency, and Speed-to-Insight Using AI & ML

Presented by Borderless Access

TRACK D

Unlocking a Deeper Understanding of the Hispanic Community

The Hispanic community in the U.S. is a mosaic of cultures, experiences, and perspectives. Not only is this dynamic population rapidly growing – projected to make up over 25% of the U.S. population by 2050 – but they also hold unmatched purchasing power, shaping the future of the marketplace. With their growing influence, this audience is essential for brands aiming to forge meaningful connections with their consumers and drive future growth. HawkPartners will demonstrate how brands can build authentic, meaningful connections with the Hispanic market by sharing market research considerations and strategies that uncover deep, actionable insights.

Presented by HawkPartners

PARTICIPANTS MAY CHOOSE 1 OF 3 CONCURRENT TRACKS

TRACK A

Leveraging AI Tools to Capture Patient Insights

Presented by AstraZeneca, Aveo Oncology an LG Chem Company, Pfizer, and Sun Pharma

TRACK B

How to Win Marketers and Influence Brand Plans

Presented by Merck, Beesy, iMarketResearch, and ThinkGen

TRACK C

Novel Market Research Techniques and Methodologies

Presented by Endo, Quest, Pfizer, Sun Pharma

Networking Cocktail Reception

Registration & Breakfast in Exhibition Hall

PARTICIPANTS MAY CHOOSE 1 OF 3 CONCURRENT TRACKS

TRACK A

Market Research and Forecasting

Presented by AstraZeneca, Novartis, Regeneron, and Takeda

TRACK B

Generative AI - Where Do We Stand Now

Presented by Bayer, Bristol Myers Squibb, Daiichi Sankyo, and Novo Nordisk

TRACK C

The Evolving Market Researcher as a Generalist/Holistic Advisor to an Organization

Presented by Amicus Therapeutics, AstraZeneca, Bayer, Chugai Pharma USA, Ionis, and Takeda

PARTICIPANTS MAY CHOOSE 1 OF 4 CONCURRENT TRACKS

TRACK A

Bridging the Gap: AI-Driven Insights for Agile Pharmaceutical Marketing

In this session, you will learn how Verilogue’s Journey Hub bridges the gap between market research and marketing teams, enabling more informed and agile decision-making in pharmaceutical marketing.

Attendees will gain valuable knowledge on:
• Integrating AI-driven insights into a patient journey and marketing plan
• Enhancing collaboration between research, marketing teams, and other departments within your organization through AI
• Improving patient-centric strategies through real-world conversations, data, and primary insights
Take advantage of this opportunity to boost your market research capabilities and learn how to effectively connect market research with marketing teams for more agile and informed decision-making.

Presented by Verilogue

TRACK B

Is Launching a New Product One Big Behavioral Change Initiative? 5 Must-Know Behavioral-Tactics for New Launches

In this entertaining presentation, we will share our learnings, provide tangible and sometimes counterintuitive examples, challenge your thinking and share 5 practical tips for optimizing new product launches that can also apply to in-market brands.

Presented by Beesy

TRACK C

Start Early With Human Truth: Building Strong Foundations for New Product Success

Successfully launching new products, and setting them up for sustained success, requires laying a strong insight and opportunity foundation early. Understanding the Human Truth of the disease state, HCPs and patients helps ensure a deep understanding of the emotional and psychological needs of the therapeutic area. This foundation can be leveraged to build patient/HCP centric roadmaps, set up future deep dives, bridge common gaps (like disconnects between HCPs and patients or KOLs and community HCPs), and creates foundational insights for faster and more efficient future launches within the therapeutic area.

Presented by Brandtrust and GlaxoSmithKline

TRACK D

The Delphi Method: A Strategic Approach to Voice of Customer Insight Generation

When visiting a sensitive, emotive topic as a means to creating or refining a communications strategy, how can you optimize the true value of the voice of your customer? Typically, in market research, respondents have one shot in a particular engagement to voice their opinions, beliefs, ideas with no transparency to how their feedback will be utilized.

This may limit ideation or their desire to invest in the topic at hand.

Enter the Delphi Method. This structured approach involves reflection, iteration, nuance, and reconsideration of opinions across multiple rounds of research where participants can see a summary of the group responses after each round, allowing them to refine their opinions until a consensus is reached. It’s a powerful method to gathering the collective thoughts of a group through an iterative process of anonymous feedback.

Join us for this presentation in which we will use a case study to showcase the benefits of mastering the Delphi Method.

Presented by Purdie Pascoe and Fresenius Kabi

PARTICIPANTS MAY CHOOSE 1 OF 4 CONCURRENT TRACKS

TRACK A

How Patient Centric Are Pharma Brands? Measuring Patient Centricity Using Advanced Social Listening and Machine Learning Analytics

Results from the largest patient centricity study across 8 disease states and 30+ biggest pharma brands

Patient centricity is a CEO-level topic in every pharma company. All brand teams spend significant time and effort in trying to be patient centric – understanding the patient journey, improving the patient experience and communicating to patients in a compassionate way.

But do patients think that pharma brands are truly patient centric? Do they believe that pharma brands understand them, or are they doing enough to help them? How do we even measure patient centricity of a pharma brand through the lens of patients? How do we go beyond a few ATU survey questions to measure patient centricity in a more comprehensive way?

In a first-of-its-kind study, Newristics will present results of a large-scale research and analysis project to measure the centricity of dozens of brands across 8 different disease states using a simultaneous stated and derived approach:

• Derived – Newristics analyzed millions of patient conversations and “derived” the level of patient centricity embedded in them using advanced social listening algorithms.

• Stated – Newristics also analyzed patient messaging of 30+ brands using machine learning models trained to score messages on manufacturer-centricity vs. patient centricity.

Don’t miss this data-backed presentation from Newristics on the #1 strategic priority topic for the pharmaceutical industry!

Presented by Newristics

TRACK B

Maximizing Brand Impact A 360-degree view of the HCP-Rep interaction

Join us on day two for an insightful presentation exploring how Research Partnership and STEM, both part of Inizio Advisory, leverage our innovative consulting methodology. Discover how we seamlessly integrate message recall and sales force effectiveness tracking with our unique, evidence-based strategy execution framework enriched by secondary data.

By leveraging STEM’s field force observations and internal stakeholder interviews with Research Partnership’s primary research findings, we connect insights on internal understanding of the brand strategy and how it is being executed with what is being communicated, recalled, and perceived by healthcare professionals (HCPs). Our combined insights help clients create optimized customer-centric strategies that enhance field engagement and drive desired HCP behavior.

Presented by Research Partnership and STEM

TRACK C

Messaging: The Power of Punch

Are short ‘punchy’ messages always the most powerful? We take a look at how various types of messages perform across different therapeutic areas and will share trends that could be helpful to any brand team.

Presented by Lieberman

TRACK D

Adaptive Intelligence: Shaping the Future of HCP and Patient Insights

In an era of rapid innovation, AI is redefining what’s possible in healthcare research. Building on our groundbreaking work modeling HCP preferences, we’ve expanded our focus to patient-centric personas. Through an AI-driven approach to message testing and persona development, we aim to empower researchers with tools that are not only faster and more cost-effective but also offer deeper understanding of rare disease patients. This session will explore the evolution of AI in healthcare insights and its potential to reshape recruitment, research agility, and patient-centric strategies.

Presented by Real Chemistry

Networking & Refreshments in Exhibition Hall

PARTICIPANTS MAY CHOOSE 1 OF 4 CONCURRENT TRACKS

TRACK A

Breaking Barriers: Delivering In-Depth Qualitative Insights Beyond Traditional Methods

By utilizing innovative methodologies and technology-driven solutions, this approach surpasses traditional limitations, providing in-depth insights that drive actionable and informed decision-making.

Presented by Instar

TRACK B

A Rare Disease Patient Segmentation with Oracle Real World Data

Presented by Oracle Life Sciences

TRACK C

Transforming Global Launches: The Impact of Human Ingenuity and AI

For many pharma teams, global launches are inherently complex undertakings. Johnson & Johnson’s launch of a promising new biologic treatment was no exception.

The challenge was extremely complex and multi-layered, with immense pressure on global stakeholders and each country lead to ensure launch success. How could the launch
message resonate with physicians across diverse cultures and healthcare systems? Achieving this required seamlessly synthesizing data from 10 distinct global markets, understanding varied healthcare professional perspectives, and crafting a unified strategy that all regional partners could align with—all while racing against time. It was a monumental task.
This session will reveal how human ingenuity paired with AI technology led to one of the most significant achievements of the biologic’s launch, the global alignment of all markets. With this approach, J&J did not have to forfeit deep, quality insights while achieving the fastest, most seamless alignment the team had ever experienced— “This is my 17th global launch, and I’ve never had such an easy time aligning regions.” More than ease, however, the process instilled a deep confidence and sense of empowerment, allowing regional teams to validate unique insights quickly and align on a core promotional message, backed by data and reinforced by local nuances.
Attendees will gain actionable takeaways, including:
✓ How GenAI is starting to be utilized in multiple ways within insights and strategy – the future is exciting.
✓ How AI paired with deep human expertise can transform the launch preparation process.
✓ Techniques for using AI to minimize confirmation bias and achieve faster, data-backed regional alignment.
✓ Methods to combine AI with behavioral science for reliable, resonant messaging across diverse healthcare contexts.
✓ Steps for balancing global consistency with regional adaptability to build trust and engagement across markets.

Presented by Shapiro+Raj and J&J Innovative Medicine

TRACK D

Making Sparks Fly: Building Lasting Partnerships for High-Value Market Research

In a world of data, it’s the human connections that make market research truly actionable This session uncovers how strong, trust-driven partnerships lead to deeper insights, aligned goals, and lasting impact.

Presented by Prescient and Bristol Myers Squibb

PARTICIPANTS MAY CHOOSE 1 OF 3 CONCURRENT TRACKS

TRACK A

What the Parable of the Blind Men and the Elephant can Teach Us about Holistic Insights

Imagine a group of blind men each describing an elephant based on the part they touch—one feels the tusk, another the tail, each convinced they have the right view of the animal.

This parable mirrors our modern business environment, where experts confidently share their insights on customers, markets, and opportunities, each from their unique perspective. In this session, we’ll delve into how these individual “truths” can be both right and wrong, and how our blind spots can limit our ability to deliver business impact. Join us to learn how insights and analytics professionals can bridge these gaps, combining diverse perspectives to “see” more comprehensive and actionable truths.

Presented by Organon

TRACK B

I Have Said It Before, and I Will Say It Again... You Are Going to Lose Your Job (Or How Not To)

• AI, machine learning (ML), and tools like ChatGPT are fundamentally transforming the Market Research discipline by streamlining processes, enhancing accuracy, and uncovering deeper insights faster than ever before
• In order to remain personally-relevant as a Market Research professional, you must acquire a new mix of technical, analytical, and soft skills aligned with these transformative technologies
• Evolution is scary, but necessary

Presented by Bristol Myers Squibb

TRACK C

Using AI in Persona Development in Market Research

Presented by EMD Serono

NETWORKING LUNCHEON

“ASK THE EXPERTS” INTERACTIVE ROUND TABLES

Explore and capture the power of participants’ Insights and experiences and exploration of these topics in this fun and informal environment in small groups. Choose 1 of 7 concurrent round tables.
ROUND TABLE 1
How to Best Partner/Collaborate with Brand Teams, Marketing Agencies, and Vendors to Deliver Actionable Insights

Presented by Ferring Pharmaceuticals

ROUND TABLE 2
Insights Support for Business Development

Presented by EMD Serono

ROUND TABLE 3
Continuous Learning for Market Research Excellence: How Market Researchers Need to Reinvent Themselves by Upskilling

Presented by Boehringer Ingelheim

ROUND TABLE 4
How to Leverage Past Research into New Research, How to Keep Research Relevant for Future Questions

Presented by AstraZeneca

ROUND TABLE 5
Harnessing Market Research: Techniques for Adapting to an Everchanging Environment

Presented by Johnson & Johnson

ROUND TABLE 6
Rage Against the Machines – Or Not? How We’re Using, and Feeling About, AI in Market Research

Presented by Merck

ROUND TABLE 7
The Death of Market Research? - Harnessing AI/ML for Enhanced Insights, Efficiency, and Impact

This session will explore how AI/ML is transforming traditional market research, from automating data/information collection and processing to synthesizing and delivering actionable insights.

We’ll examine the challenges and opportunities at the intersection of AI/ML and market research, highlighting the impact of these technologies on both individual roles and organizational strategies.

The discussion will kick off with participants sharing practical applications of AI/ML, showcasing real-world examples of how these tools are revolutionizing the field. We’ll then look ahead, considering how AI/ML will continue to reshape the role of market researchers and elevate their strategic value within organizations. Finally, we’ll explore strategies for upskilling researchers to effectively integrate advanced tools into their workflows, potentially redefining their positioning and ensuring they remain at the forefront of an evolving industry.

Presented by AstraZeneca

Raffle Prize Winners Announcements

Summary and Key Takeaways By Advisory Board Members

Presented by Aveo Oncology an LG Chem Company, Immunovant, J&J Innovative Medicine, Merck, Organon, Pfizer, Regeneron, and Sun Pharma

Conference Concludes